Treat Arterial Hypertension and Diabetes in Rural Africa (TAHADIRA)
Primary Purpose
Diabetes, Arterial Hypertension
Status
Completed
Phase
Not Applicable
Locations
Cameroon
Study Type
Interventional
Intervention
Treatment contract
Tracing and recall at home by a community worker
Incentive
Sponsored by

About this trial
This is an interventional health services research trial for Diabetes focused on measuring Primary Health care in rural Africa, Chronic non-communicable diseases, Patient Compliance, Treatment adherence
Eligibility Criteria
Inclusion Criteria:
- Patients with newly diagnosed arterial hypertension or non insulin dependent diabetes type 2 which require treatment and can be treated in the health centre
- Informed consent by the patient
Exclusion Criteria:
- Patient already under treatment
- Patients who need to be referred to a hospital
- No informed consent by the patient
Sites / Locations
- Medical districts of Mfou, Mbankomo Obala and Esse in Central Cameroon
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
1
2
3
Arm Description
Outcomes
Primary Outcome Measures
Percentage of patients with regular follow-up one year after the treatment was started
Secondary Outcome Measures
Percentage of missed control-visits
Treatment response of diabetic patients (fasting blood glucose)
Treatment response of patients with arterial hypertension (blood pressure)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00744458
Brief Title
Treat Arterial Hypertension and Diabetes in Rural Africa
Acronym
TAHADIRA
Official Title
A Prospective Randomised Trial Comparing Three Interventions to Improve Treatment Adherence Among Patients With Arterial Hypertension or Diabetes in Rural Cameroon (TAHADIRA-trial 1)
Study Type
Interventional
2. Study Status
Record Verification Date
August 2009
Overall Recruitment Status
Completed
Study Start Date
August 2008 (undefined)
Primary Completion Date
February 2010 (Actual)
Study Completion Date
February 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Cooperation Afrique
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine the efficacy of three different interventions to improve treatment adherence among patients with arterial hypertension or diabetes in rural Cameroon.
Detailed Description
Non communicable chronic diseases such as arterial hypertension (AH) and diabetes (DM) are a great burden for public health in Cameroon. However, outside the main cities access to appropriate diagnosis and treatment of these health-conditions is still very poor.
The Swiss NGO "Fondation Coopération Afrique" started in 2007 a program to integrate chronic disease management with focus on AH and DM into the primary health care system of peripheral non-physician health facilities in a rural area of Central Cameroon. A first evaluation after one year revealed very low treatment adherence among the newly diagnosed patients as the main challenge.
In order to improve patient's adherence we expose them randomly to one of three interventions:
The first intervention consists in a written agreement on long-lasting therapy (treatment contract). Patients get information about the importance of a regular long term treatment and personal engagement to follow treatment and clinical controls regularly.
The second intervention introduces in addition to the treatment contract a reminder system. In case of follow-up failure a community worker traces the patient to recall the visit at the health centre.
The third intervention consists of the treatment contract combined with a financial incentive in form of one month free treatment after four months of regular follow-up.
We allocated randomly one of the three interventions to each health center.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Arterial Hypertension
Keywords
Primary Health care in rural Africa, Chronic non-communicable diseases, Patient Compliance, Treatment adherence
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
223 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Active Comparator
Arm Title
2
Arm Type
Active Comparator
Arm Title
3
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Treatment contract
Intervention Description
Patients signs in for a agreement - to respect a regular follow-up at the health facility.
Intervention Type
Other
Intervention Name(s)
Tracing and recall at home by a community worker
Intervention Description
The local health committee sends out a member to trace the patient and to motivate him to take up again regular treatment visits.
Intervention Type
Other
Intervention Name(s)
Incentive
Intervention Description
Incentive by giving free treatment after a 4-month regular follow-up
Primary Outcome Measure Information:
Title
Percentage of patients with regular follow-up one year after the treatment was started
Time Frame
One patient year
Secondary Outcome Measure Information:
Title
Percentage of missed control-visits
Time Frame
One patient year
Title
Treatment response of diabetic patients (fasting blood glucose)
Time Frame
One patient year
Title
Treatment response of patients with arterial hypertension (blood pressure)
Time Frame
One patient year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with newly diagnosed arterial hypertension or non insulin dependent diabetes type 2 which require treatment and can be treated in the health centre
Informed consent by the patient
Exclusion Criteria:
Patient already under treatment
Patients who need to be referred to a hospital
No informed consent by the patient
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Engelbert Manga, MD, MPH
Organizational Affiliation
Medical district officer of Mfou, Ministry of public health of Cameroon
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Niklaus D Labhardt, MD
Organizational Affiliation
Representant of the foundation Coopération Afrique, Switzerland
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Beat Stoll, MD, MPH
Organizational Affiliation
Institute of social and preventive medicine, University of Geneva, Switzerland
Official's Role
Study Chair
Facility Information:
Facility Name
Medical districts of Mfou, Mbankomo Obala and Esse in Central Cameroon
City
Divisions of Mefou and Lékié
State/Province
Central Province
ZIP/Postal Code
4056
Country
Cameroon
12. IPD Sharing Statement
Learn more about this trial
Treat Arterial Hypertension and Diabetes in Rural Africa
We'll reach out to this number within 24 hrs